Related Experiment Video

Updated: Jun 5, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance

Sophie Turban1, Eric Hajduch

  • 1Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.

FEBS Letters
|December 24, 2010
PubMed

Insights

Protein Kinase C (PKC) roles in insulin signaling are complex. Atypical PKCs (aPKCs) are key molecular switches, but their function in glucose metabolism and insulin resistance requires further investigation.

Area of Science:

  • Biochemistry
  • Cellular Metabolism
  • Endocrinology

Background:

  • Protein Kinase C (PKC) isoforms play a complex role in insulin-regulated glucose metabolism.
  • Conventional and novel PKCs can counteract insulin signaling, particularly upon activation by diacylglycerol (DAG).
  • The specific functions of atypical PKCs (aPKCs) in this context are not well understood.

Purpose of the Study:

  • To elucidate the role of atypical PKCs (aPKCs) in insulin signaling.
  • To understand how DAG- and ceramide-activated PKCs impact glucose metabolism.
  • To identify potential therapeutic targets for combating insulin resistance.

Main Methods:

  • Investigating the signaling pathways regulated by atypical PKCs.
  • Analyzing the effects of PKC activation by DAG and ceramides on insulin signaling.
  • Utilizing cellular and biochemical assays to study glucose metabolism.

Main Results:

  • Atypical PKCs function as molecular switches, modulating signaling pathways.
  • Insulin activates pathways that promote signaling, while ceramides activate pathways that suppress it.
  • Understanding these mechanisms is crucial for addressing insulin resistance.

Conclusions:

  • Atypical PKCs are critical regulators of insulin signaling and glucose metabolism.
  • Elucidating the precise roles of different PKC isoforms can lead to novel therapeutic strategies.
  • Targeting DAG- and ceramide-activated PKCs may offer a way to combat insulin resistance.

More Related Videos

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...